Delivery Order SPE2DB20D3303-SPE2DB25FY1C3

Award Date 10/11/24
Potential Completion Date 10/15/24
Potential Value $9.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of Candesartan Cilexetil 16 mg tablets, a prescription medication. The contract has a ceiling value of $39,839.69 and an ultimate completion date of September 6, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical,...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Candesartan Cilexetil 32 mg tablets. The contract has an ultimate completion date of January 24, 2025 and a ceiling value of $15,714.20. AmerisourceBergen is a major pharmaceutical distributor that has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle for providing a wide range...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Candesartan Cilexetil 16 mg tablets. The contract has a ceiling value of $2,277.09 and a period of performance ending on August 2, 2024. The contract is a firm-fixed-price delivery order and does not have a set-aside designation. This contract award is associated with a larger Indefinite Delivery Contract (IDC) between...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Candesartan Cilexetil 32 mg tablets in 90-count packages, with a ceiling value of $6,296.40 and an ultimate completion date of January 8, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,832.28, is for the provision of Candesartan Cilexetil 32 mg tablets. The contract is a firm fixed-price delivery order with a period of performance through November 6, 2024. The contract was not set aside for any specific business type. AmerisourceBergen Drug Corp holds a larger...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,490.93 firm-fixed-price contract is for the delivery of Candesartan Cilexetil 16 mg tablets over a period ending on January 30, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract, valued at $7,897.46, is for the delivery of 4,567,137,152 units of Candesartan Cilexetil 16 mg tablets in 90-count bottles. The contract has an ultimate completion date of February 4, 2025 and utilizes a firm fixed-price pricing structure. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued...
This is a delivery order under an Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract provides Candesartan Cilexetil 32 mg tablets to the DLA in support of military and veterans' healthcare programs. The delivery order has a ceiling value of $5,329.99 and was awarded on September 23, 2021, with a completion date of September 24, 2021. The contract is a firm...
This federal contract award, valued at $12,009.82, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Candesartan Cilexetil 32 mg tablets. The contract is a Firm Fixed Price Delivery Order with a performance period through January 30, 2025. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as the primary vehicle for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The contract is for the supply of 32 mg Candesartan Cilexetil tablets, a pharmaceutical product, and has a ceiling value of $14,864.29. The contract is a firm-fixed price delivery order with an ultimate completion date of October 16, 2024. Amerisourcebergen is a major supplier of pharmaceutical and medical products to the U.S....
  • SPE2DB20D3303
    Indefinite Delivery Contract
  • SPE2DB20D3303-SPE2DB25FY1C3
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Candesartan Cilexetil 32 mg tablets. The contract has a firm fixed price ceiling value of $9,059.79 and a period of performance extending to October 15, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, valued at up to $999,999,999 through December 2025, for the provision of a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 1/10/25, 9:17 AM